Keine aktuellen Kursdaten verfügbar |
Zeit | Titel | Quelle |
30.09.16 | EU Marketing Authorization Granted for Teva's Aerivio Spiromax® (fluticasone/salmeterol 500/50) | PR Newswire |
30.05.16 | Teva Achieves Positive Conclusion for the European Decentralised Procedure (DCP) for BRALTUS® (tiotropium bromide) | PR Newswire |
Kaufen | Halten | Verkaufen | |
---|---|---|---|
Analysten | 0 | 0 | 0 |
Markt-Lotsen | 0 | 0 | 0 |